Male urinary tract symptoms (M-LUTS) belong to common complaints that are treated with drugs from several pharmacotherapeutic groups, with different mechanism of action, different mechanism of adverse affects and associated potential drug related problems. When choosing a suitable drug, it is necessary to assess patients' general health status and concomitant medication, in order to minimize the risk of adverse effects in predisposed individuals.
The text presented here summarizes current approach to the pharmacotherapy of M-LUTS and in several case reports demonstrates possible drug-related problems associated with this therapy.